Researchers at the University of Pennsylvania are advancing lung cancer surgery by combining intraoperative molecular imaging (IMI) with a novel near-infrared contrast agent and preoperative PET/CT scans to help surgeons better see and extract both obvious and hard-to-find tumors. {read more here}